Reuters logo
BRIEF-Neimeth International Pharmaceuticals CEO Ebere Igboko Ekpunobi resigns
September 27, 2017 / 5:09 PM / 2 months ago

BRIEF-Neimeth International Pharmaceuticals CEO Ebere Igboko Ekpunobi resigns

Sept 27 (Reuters) - Neimeth International Pharmaceuticals Plc:

* NEIMETH INTERNATIONAL PHARMACEUTICALS - CEO EBERE IGBOKO EKPUNOBI RESIGNS FROM BOARD, DUE TO MEDICAL CONDITION FROM SPORTING INJURY

* NEIMETH INTERNATIONAL - ANNOUNCES APPOINTMENT OF CHRIS U MMEJE, FINANCE DIRECTOR OF CO SINCE 2008, AS ACTING MANAGING DIRECTOR/CEO WITH IMMEDIATE EFFECT‍​

* NEIMETH INTERNATIONAL PHARMACEUTICALS - CEO EBERE IGBOKO EKPUNOBI RESIGNED ON SEPT.11

* NEIMETH INTERNATIONAL - MMEJE WILL OVERSEE AFFAIRS OF COMPANY UNTIL THE EMERGENCE OF A SUBSTANTIVE MANAGING DIRECTOR Source text for Eikon: [bit.ly/2fRAXxZ] Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below